CLINICAL_TRIALS
trial_result
· 2016-08-19
Clinical Trial Update: Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women. [Phase 2]
Summary
Phase 2 trial evaluating 851B Gel for high-risk cervical human papillomavirus infection in women has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Papillomavirus Infections | Phase 2 | Status: TERMINATED